Skip to main content

Primary histiocytic sarcoma of the clivus with focal extension into central nervous system and neurologic manifestations: First description at an unusual site with an overwhelming and rapid progression.

Publication ,  Journal Article
Perez, I; Gokden, M; Day, JD; Yaziji, H; Pina-Oviedo, S
Published in: Clin Neuropathol
2022

Histiocytic sarcoma (HS) is a rare malignant neoplasm of macrophage-dendritic cell lineage that can occur at any site. Primary base of skull involvement is exceedingly rare. We present the case of a previously healthy 56-year-old man who complained of headaches and showed localized neurologic symptoms. Magnetic resonance imaging demonstrated a hyperintense and enhancing mass involving the sphenoid bone and the clivus with an extradural component that compressed the distal pons. The differential diagnosis included chordoma or chondrosarcoma. An endoscopic trans-sphenoidal resection was performed. Microscopically, the tumor showed epithelioid and spindle morphology with atypia, mitoses, and necrosis. No osteoid, cartilaginous, or myxoid matrix was identified. By immunohistochemistry, the tumor was positive for CD68 (KP-1) and lysozyme, variably positive for CD4, CD11c, CD14, CD68 (PGM-1), CD45, and CD163, and negative for markers of epithelial, melanocytic, lymphoid, myeloid, muscle, and dendritic cell origin. Expression of PD-L1 by immunohistochemistry and BRAF V600E mutation analysis by PCR were negative. Tumor recurrence developed after radiation treatment with overwhelming progression into a largely infiltrating mass within 2 weeks with clinical deterioration, and the patient died 3 months later. To our knowledge, this represents the first case of primary HS of the clivus reported to date in the English literature, further expanding the spectrum of neoplasms seen at this site as well as the sites where HS can be seen. The overall prognosis of HS in the skull base is poor, with no standard treatment. Further research is warranted to develop effective treatment approaches, which in the future may rely on the expression of checkpoint inhibitors and/or specific molecular markers.

Duke Scholars

Published In

Clin Neuropathol

DOI

ISSN

0722-5091

Publication Date

2022

Volume

41

Issue

2

Start / End Page

74 / 82

Location

Germany

Related Subject Headings

  • Neurology & Neurosurgery
  • Neoplasm Recurrence, Local
  • Middle Aged
  • Male
  • Immunohistochemistry
  • Humans
  • Histiocytic Sarcoma
  • Cranial Fossa, Posterior
  • Central Nervous System
  • 5202 Biological psychology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Perez, I., Gokden, M., Day, J. D., Yaziji, H., & Pina-Oviedo, S. (2022). Primary histiocytic sarcoma of the clivus with focal extension into central nervous system and neurologic manifestations: First description at an unusual site with an overwhelming and rapid progression. Clin Neuropathol, 41(2), 74–82. https://doi.org/10.5414/NP301400
Perez, Ivette, Murat Gokden, John D. Day, Hadi Yaziji, and Sergio Pina-Oviedo. “Primary histiocytic sarcoma of the clivus with focal extension into central nervous system and neurologic manifestations: First description at an unusual site with an overwhelming and rapid progression.Clin Neuropathol 41, no. 2 (2022): 74–82. https://doi.org/10.5414/NP301400.

Published In

Clin Neuropathol

DOI

ISSN

0722-5091

Publication Date

2022

Volume

41

Issue

2

Start / End Page

74 / 82

Location

Germany

Related Subject Headings

  • Neurology & Neurosurgery
  • Neoplasm Recurrence, Local
  • Middle Aged
  • Male
  • Immunohistochemistry
  • Humans
  • Histiocytic Sarcoma
  • Cranial Fossa, Posterior
  • Central Nervous System
  • 5202 Biological psychology